Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Perspective Random Trial of Sodium Glycididazole Combined With Definitive Concurrent Chemoradiotherapy for Locally Advanced Squamous Cell Esophageal Carcinoma

NCT02721563 is registered in ClinicalTrials.gov with Shandong Cancer Hospital and Institute as lead sponsor.

NCT NCT02721563
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02721563 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Perspective Random Trial of Sodium Glycididazole Combined With Definitive Concurrent Chemoradiotherapy for Locally Advanced Squamous Cell Esophageal Carcinoma
Lead sponsor
Shandong Cancer Hospital and Institute
Phase
Phase 4
Overall status
Completed
Start date
February 25, 2016
Completion date
June 30, 2018
Enrollment
77 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

esophageal neoplasms